Recent

  • Show all results for ""

🎧 New: AI-Generated Podcasts Turn your study notes into engaging audio conversations. Learn more

Antimicrobial Resistance in Gram-Negative Pathogens
64 Questions
0 Views

Antimicrobial Resistance in Gram-Negative Pathogens

Created by
@QuickerDatePalm

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism of action of tigecycline, minocycline, and eravacycline?

  • Interference with DNA replication
  • Inhibition of protein synthesis (correct)
  • Disruption of the bacterial membrane
  • Inhibition of cell wall formation

    • Which of the following is a key factor contributing to the rapid spread of antimicrobial resistance among Gram-negative pathogens?

  • Lack of public awareness about antimicrobial resistance
  • Overuse/misuse of existing antimicrobials (correct)
  • Underuse of existing antimicrobials
  • Insufficient research into new antimicrobial agents

    • Which type of infection is predominantly associated with ventilator-associated pneumonia (VAP), invasive devices, immune-suppression, prior antibiotic use, and aggressive medical procedures?

  • Urinary tract infections
  • Severe life-threatening infections (correct)
  • Gastrointestinal infections
  • Skin and soft tissue infections

    • What is the primary characteristic of carbapenem-resistant Acinetobacter baumannii (CRAB) that affects patient outcomes?

    <p>Multidrug-resistance</p> Signup and view all the answers

    What is the primary consideration for healthcare professionals when deciding which antimicrobial to use for healthcare-associated infections?

    <p>Intrinsic pathogen-specific characteristics</p> Signup and view all the answers

    Which of the following antimicrobials is known to retain its activity many times better than tigecycline?

    <p>Eravacycline</p> Signup and view all the answers

    What is the primary consequence of the increasing emergence of resistance to last-line therapy options?

    <p>Re-purposing of polymyxins for the treatment of severe bacterial infections</p> Signup and view all the answers

    Which of the following is a key aspect of antimicrobial stewardship programs?

    <p>Optimizing the use of existing antimicrobials</p> Signup and view all the answers

    What is the primary outcome of using antibiotic treatment of CRAB infections according to the experimental evidence?

    <p>Acceptable clinical and microbiological effectiveness</p> Signup and view all the answers

    What is the main limitation of previous studies comparing tigecycline, minocycline, and eravacycline in treating CRAB infections?

    <p>They did not propose a meta-analysis</p> Signup and view all the answers

    What is the unique property of minocycline that tigecycline does not share?

    <p>All of the above</p> Signup and view all the answers

    What is the main difference between tigecycline and minocycline in terms of their structural composition?

    <p>Tigecycline is a glycylcycline, while minocycline is a tetracycline</p> Signup and view all the answers

    What was the outcome of the Phase III trials comparing tigecycline with imipenem/cilastatin as monotherapy for hospital-acquired pneumonia?

    <p>No significant difference between the two treatment arms was observed</p> Signup and view all the answers

    What is the percentage of septic strains of Acinetobacter baumannii that were sensitive to tigecycline in published in vitro studies?

    <p>90-98%</p> Signup and view all the answers

    What is the primary concern with using tigecycline in patients with a higher comorbidity index?

    <p>Neurotoxicity symptoms</p> Signup and view all the answers

    What is the purpose of integrating clinical microbiological monitoring in the treatment of CRAB infections?

    <p>To monitor serious or less common welfare adverse events</p> Signup and view all the answers

    What is the primary advantage of tigecycline over other tetracycline drugs?

    <p>Increased activity against tetracycline-resistant pathogens</p> Signup and view all the answers

    What is the main limitation of using tetracycline drugs in the treatment of CRAB infections?

    <p>Bacterial-mediated resistance</p> Signup and view all the answers

    What is the primary mechanism of action of tigecycline?

    <p>Inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit</p> Signup and view all the answers

    What is the limitation of tigecycline use in the treatment of central nervous system infections?

    <p>Low concentration in cerebrospinal fluid</p> Signup and view all the answers

    What is the characteristic of minocycline that makes it effective against resistant Acinetobacter species?

    <p>Additional activity at high concentrations</p> Signup and view all the answers

    What is the mechanism of action of eravacycline in inhibiting bacterial protein translation?

    <p>By preventing tRNA binding to ribosomes and by stalling the ribosomes during elongation</p> Signup and view all the answers

    What is the characteristic of eravacycline that contributes to its high volume of distribution and tissue penetration?

    <p>Presence of a nonpolar substituent at position 9</p> Signup and view all the answers

    What is the primary route of elimination of eravacycline from the organism?

    <p>Renal excretion and nonenzymatic degradation</p> Signup and view all the answers

    What is the indication for which eravacycline was approved by the FDA in 2018?

    <p>Complicated urinary tract and intra-abdominal infections</p> Signup and view all the answers

    What is the characteristic of tigecycline that makes it effective against methicillin-resistant and vancomycin-resistant S. aureus?

    <p>Broad spectrum of antibacterial action</p> Signup and view all the answers

    What is the effect of minocycline on keratinization ducts in the treatment of acne vulgaris?

    <p>Decreases sebum production and proliferation</p> Signup and view all the answers

    What is the year in which minocycline was first reported?

    <p>1957</p> Signup and view all the answers

    What is the primary advantage of using minocycline over eravacycline?

    <p>It has higher concentrations in lung tissue</p> Signup and view all the answers

    Which antibiotic is not one of the most powerful alternatives to tigecycline?

    <p>Tigecycline</p> Signup and view all the answers

    What is the main limitation of using tigecycline as a treatment for CRAB infections?

    <p>It is not perfect and may not predict clinical response</p> Signup and view all the answers

    What is the significance of the in vitro susceptibility rates of tigecycline against CRAB?

    <p>It indicates that our isolates are still sensitive to tigecycline</p> Signup and view all the answers

    Why is it necessary to consider alternative options to tigecycline for treating CRAB infections?

    <p>Because tigecycline is not perfect and may not predict clinical response</p> Signup and view all the answers

    What is the main advantage of using minocycline as an alternative to tigecycline and eravacycline?

    <p>It appears to overcome greater resistance in vitro</p> Signup and view all the answers

    What is a potential limitation of the Cox or logistic regression analyses used in some studies?

    <p>Insufficient number of covariates included for adjustment</p> Signup and view all the answers

    Which antibiotic was approved by the FDA in 2003?

    <p>Tigecycline</p> Signup and view all the answers

    What is the primary efficacy endpoint in the clinical trials evaluating tigecycline?

    <p>Response of clinical efficacy in shorter indications</p> Signup and view all the answers

    Which antibiotic has the most favorable safety profile in the treatment of CRAB infections?

    <p>Minocycline</p> Signup and view all the answers

    What is a common side effect of tigecycline?

    <p>Digestive symptoms</p> Signup and view all the answers

    What is a potential limitation of eravacycline in the treatment of CRAB infections?

    <p>Limited safety data</p> Signup and view all the answers

    What is the percentage of patients who discontinued eravacycline treatment due to severe side effects?

    <p>80%</p> Signup and view all the answers

    What is a common side effect of minocycline?

    <p>Mild itching</p> Signup and view all the answers

    What is a potential consequence of using tigecycline in patients?

    <p>Increased risk of mortality</p> Signup and view all the answers

    Why was eravacycline considered as an available option for CRAB infections?

    <p>It has good safety profiles</p> Signup and view all the answers

    What is the main advantage of eravacycline over tigecycline?

    <p>Eravacycline has a better pharmacokinetic (PK) profile than tigecycline</p> Signup and view all the answers

    What is the MIC50 value of eravacycline?

    <p>0.5 mg/L</p> Signup and view all the answers

    Against which type of bacteria is eravacycline ineffective in vitro?

    <p>CRAB</p> Signup and view all the answers

    What is the significance of eravacycline's ability to reduce OXA-23 production levels?

    <p>It suggests that eravacycline has superior time- and concentration-dependent bacterial killing</p> Signup and view all the answers

    What is the main limitation of using minocycline in treating CRAB infections?

    <p>It has variable in vitro activity against CRAB</p> Signup and view all the answers

    What is the finding of a recent meta-analysis by Cai et al. regarding tigecycline?

    <p>Tigecycline performs equally well to polymyxin B and associates with higher treatment mortality</p> Signup and view all the answers

    What is the significance of eravacycline's ability to restore in vitro activity against tigecycline-resistant strains?

    <p>It implies that eravacycline is effective against a broader range of pathogens</p> Signup and view all the answers

    What is the advantage of using eravacycline over minocycline in treating CRAB infections?

    <p>Eravacycline has a more consistent in vitro activity against CRAB</p> Signup and view all the answers

    What is the main difference between eravacycline and tigecycline in terms of their pharmacokinetic profiles?

    <p>Eravacycline has a better pharmacokinetic (PK) profile than tigecycline</p> Signup and view all the answers

    What is the significance of the study by James E. Sanger regarding the combination of tigecycline and minocycline?

    <p>It indicates that the combination of tigecycline and minocycline is effective against CRAB</p> Signup and view all the answers

    What was the consequence of the higher mortality in patients who received tigecycline versus those given other antibiotics?

    <p>The US FDA issued a warning about tigecycline safety.</p> Signup and view all the answers

    What is the most common fluid overload-associated tigecycline adverse event?

    <p>Acute kidney injury (AKI).</p> Signup and view all the answers

    What is the consequence of combining tigecycline with colistin?

    <p>An increase in acute kidney injury events.</p> Signup and view all the answers

    What percentage of patients who received tigecycline had at least 1 episode of elevated aminotransferase levels?

    <p>50%</p> Signup and view all the answers

    Why is tigecycline's use in clinical practice being revisited?

    <p>All of the above.</p> Signup and view all the answers

    What is the recommended approach when administering tigecycline to critically ill patients?

    <p>Monitor kidney function and resuscitation.</p> Signup and view all the answers

    What is the difference between tigecycline and minocycline in terms of adverse events?

    <p>Minocycline has a lower rate of adverse events compared to tigecycline.</p> Signup and view all the answers

    What is a unique adverse effect associated with minocycline?

    <p>All of the above.</p> Signup and view all the answers

    What is the current status of eravacycline?

    <p>It is a possible therapeutic option of last resort based on preclinical studies.</p> Signup and view all the answers

    What is the recommended approach when using tigecycline in patients with end-stage diseases?

    <p>Dosage adjustment is required.</p> Signup and view all the answers

    Study Notes

    Antibiotic Resistance and Treatment of Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections

    • CRAB infections are associated with high mortality and morbidity rates, and are often linked to severe life-threatening infections such as pneumonia and bacteremia.
    • Tigecycline, minocycline, and eravacycline are non-β-lactam antimicrobials that act by inhibiting protein synthesis and have been considered as therapeutic options for treating CRAB infections.

    Mechanisms of Action

    • Minocycline's unique property is its ability to diffuse into tissues and cellular compartments, cross the blood-brain barrier, and water solubility.
    • Tigecycline is a glycylcycline and a member of the cycline drug class, which is structurally different from other drug classes.
    • Eravacycline uses the tetracycline backbone but is structurally distinct from tigecycline, with a variety of substitutions on the ABC group at position 9 and position 1 being replaced by an amidine-like functional group.

    Pharmacotherapeutic Cycles

    • Tigecycline has demonstrated good activity against Acinetobacter baumannii, but its use has many limitations, including a large volume of distribution and low concentration in cerebrospinal fluid.
    • Minocycline's spectrum of activity varies considerably, and it has additional activity against resistant Acinetobacter species, acquired resistance D-alanine-D-lactamases, and polymyxin resistance.
    • Eravacycline has a broad-spectrum activity against a range of pathogens and has a minimal inhibitory concentration (MIC50) of 0.5 mg/L.

    Efficacy Studies

    • Eravacycline restores in vitro activity when MRSA, VRE, and ESBLs exhibit resistance to tigecycline.
    • Minocycline is increasingly recognized as an antibiotic with action against some other resistant pathogens as well, but its in vitro activity against CRAB is variable.

    Safety Profiles

    • Minocycline is considered to have the most favorable safety profile when administered as a therapy of CRAB infections.
    • Tigecycline has quite poor tolerability due to digestive symptoms and is associated with a significant increase in mortality risk in patients.
    • Eravacycline has a good safety profile, but no safety data are available for pregnant women.

    Adverse Effects

    • Tigecycline use can cause acute kidney injury (AKI) and liver function test abnormalities.
    • Tigecycline in combination with colistin is characterized most commonly by an increase in the acute kidney injury event.
    • Minocycline has a lower rate of adverse events compared to tigecycline, with the most common non-central nervous system-related adverse events being dizziness, vertigo, discoloration of urine and/or teeth, nausea, and lower gastrointestinal disorders.### Adverse Effects of Minocycline
    • Minocycline is associated with a black discoloration of thyroid tissue and a reversible gray-brown discoloration of the teeth.
    • Minocycline can cause a brown discoloration of the nails, which is related to inflammatory acne vulgaris.
    • Gastrointestinal adverse effects of minocycline are less common than those of tigecycline.

    Comparison of Minocycline and Tigecycline

    • Tigecycline has a higher rate of nausea-vomiting compared to minocycline.
    • Tigecycline is associated with pancreatitis, increased risk of mortality, skin side effects, and changes in laboratory study results.
    • Minocycline achieves high concentrations in lung tissue, making it useful in complex pneumonias.

    Eravacycline and CRAB Infections

    • Eravacycline is a possible therapeutic option of last resort for CRAB infections, but clinical data is needed.
    • In vitro susceptibility rates to tigecycline are high enough (90%) to consider CRAB isolates still sensitive.
    • Minocycline, tigecycline, and eravacycline should be used in combination, from least to most evidence, to treat CRAB infections.
    • Fosfomycin, meropenem-vaborbactam, and cefiderocol are the most active alternative therapies, with 100% susceptibility.

    Key Findings

    • Minocycline has higher in vitro susceptibility rates than eravacycline.
    • Tigecycline has protection by the earlier intravenous dose.
    • Minocycline has values that reach the maximum of the seminal plasma.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the increasing emergence of resistance to last-line therapy options and the re-purposing of polymyxins for the treatment of severe bacterial infections caused by Gram-negative pathogens.

    More Quizzes Like This

    Antimicrobial Resistance (AMR) Quiz
    6 questions

    Antimicrobial Resistance (AMR) Quiz

    IdealScholarship2438 avatar
    IdealScholarship2438
    Drug Penetration and Efflux in Gram-Negative Organisms
    33 questions

    Drug Penetration and Efflux in Gram-Negative Organisms

    GrandTheme avatar
    GrandTheme
    Antimicrobial Resistance and Mutagenesis Quiz
    40 questions

    Antimicrobial Resistance and Mutagenesis Quiz

    UnboundAltoFlute avatar
    UnboundAltoFlute
    Carbapenem-Resistant GNB Infections Treatment
    32 questions

    Carbapenem-Resistant GNB Infections Treatment

    QuickerDatePalm avatar
    QuickerDatePalm
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser